Trials / Completed
CompletedNCT00964275
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein
Study of Positron Emission Tomography With 18-fluorodeoxyglucose in Detecting Cancer in Patients With Idiopathic Venous Thromboembolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 positron emission tomography, may help find and diagnose cancer. It is not yet known whether standard diagnostic procedures are more effective when given with or without fludeoxyglucose F 18 positron emission tomography in finding cancer. PURPOSE: This randomized clinical trial is studying fludeoxyglucose F 18 positron emission tomography given together with standard diagnostic procedures to see how well it works compared with standard diagnostic procedures alone in finding cancer in patients with a blood clot in a vein.
Detailed description
OBJECTIVES: Primary * Demonstrate the efficacy, in terms of increased numbers of cancer diagnoses, of PET-CT with 18-FDG in patients with idiopathic venous thromboembolism. Secondary * Assess the risk of cancer detected at 1 year. * Assess whether PET allows earlier detection of cancer. * Evaluate survival. OUTLINE: This is a multicenter study. All patients undergo standard (clinical and biological) diagnostic tests for cancer. Patients are randomized to 1 of 2 diagnostic arms. * Arm I: Patients undergo diagnostic fludeoxyglucose F 18 PET in addition to standard methods. * Arm II: Patients only undergo standard diagnostic methods. Patients are followed up for 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | diagnostic procedure | Standard diagnostic procedures followed |
| RADIATION | fludeoxyglucose F 18 | PET with flueoxyglucose F 18 |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2009-08-24
- Last updated
- 2014-12-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00964275. Inclusion in this directory is not an endorsement.